NCT04259814

Brief Summary

Modified constraint-induced movement therapy (mCIMT) has been successfully used with children who have hemiplegia (weakness or paralysis on one side of the body.) mCIMT uses a removable cast during treatment and home exercise programs. It has been found that mCIMT can improve use, strength and coordination of a child's affected hand, and may also help improve speech and language skills. The goal of this project is to investigate whether combining mCIMT with speech therapy will enhance speech outcomes in children with cerebral palsy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
3

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2020

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 6, 2020

Completed
29 days until next milestone

First Submitted

Initial submission to the registry

February 4, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 7, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 26, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 26, 2020

Completed
Last Updated

September 21, 2021

Status Verified

September 1, 2021

Enrollment Period

5 months

First QC Date

February 4, 2020

Last Update Submit

September 20, 2021

Conditions

Keywords

speech delayone-sided weakness

Outcome Measures

Primary Outcomes (1)

  • Probes

    Number of trained words and phrases produced during a treatment session.

    Up to 15 weeks

Secondary Outcomes (3)

  • Mean Length of Utterance

    Up to 15 weeks

  • Test of Early Language Development (TELD)

    Up to 15 weeks

  • Goldman-Fristoe Test of Articulation-2 (GFTA-2)

    Up to 15 weeks

Study Arms (1)

Speech-Language Treatment plus mCIMT

EXPERIMENTAL

4 participants Baseline phase: Speech-language treatment (SLT), 1 hour a day, 3 days a week. The length of the baseline phase will be staggered across subjects. Treatment phase: SLT combined with modified constraint-induced movement therapy(mCIMT) 1 hour a day, 3 days a week. Total of baseline and treatment sessions will be 20 to 30 sessions.

Behavioral: Speech-language therapy (SLT)Behavioral: Modified constraint-induced movement therapy (mCIMT)

Interventions

Age-appropriate play activities with speech-language pathologist (SLP) to elicit speech, using stimulation strategies including but not limited to recasts, expansion, parallel talk, interactive modeling, communication temptations, and phrase completions. Activities will include an age-appropriate story, pretend play (i.e., house with people, playing with a baby doll), an assembly task (i.e., building blocks, making pretend pizza), and a highly motivating, clinician-controlled activity (i.e., blowing bubbles, swing, pushing cars down a ramp).

Speech-Language Treatment plus mCIMT

Participants will wear a removable cast and an occupational therapist will be present during therapy to focus on facilitating play with the affected arm.

Speech-Language Treatment plus mCIMT

Eligibility Criteria

Age15 Months - 7 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Previous diagnosis of Cerebral Palsy
  • Hemiplegia
  • Speech-Language Impairment
  • English as primary language spoken in the patient's home
  • Normal or corrected hearing and vision

You may not qualify if:

  • Presence of co-morbid developmental disability (not including specific language impairment) which has an impact on cognition, sensory processing, and/or social-pragmatic function
  • Non-corrected hearing loss as evidenced by audiology report, failure to pass a newborn hearing screening, and/or performance on pure-tone testing.
  • Non-corrected vision impairments
  • Weakness on both sides or neither side of the body
  • Bilingual speakers or patients who speak languages other than English
  • Previous history of CIMT or mCIMT within the past 6 months.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shirley Ryan AbilityLab

Chicago, Illinois, 60611, United States

Location

Related Publications (3)

  • Naylor CE, Bower E. Modified constraint-induced movement therapy for young children with hemiplegic cerebral palsy: a pilot study. Dev Med Child Neurol. 2005 Jun;47(6):365-9. doi: 10.1017/s0012162205000721.

    PMID: 15934484BACKGROUND
  • Sigurdardottir S, Vik T. Speech, expressive language, and verbal cognition of preschool children with cerebral palsy in Iceland. Dev Med Child Neurol. 2011 Jan;53(1):74-80. doi: 10.1111/j.1469-8749.2010.03790.x. Epub 2010 Oct 11.

    PMID: 21039439BACKGROUND
  • Allison KM, Reidy TG, Boyle M, Naber E, Carney J, Pidcock FS. Speech production gains following constraint-induced movement therapy in children with hemiparesis. J Pediatr Rehabil Med. 2017;10(1):3-9. doi: 10.3233/PRM-170405.

    PMID: 28339405BACKGROUND

MeSH Terms

Conditions

SpeechLanguage DisordersCerebral PalsyHemiplegiaParesisLanguage Development Disorders

Interventions

Speech Therapy

Condition Hierarchy (Ancestors)

Verbal BehaviorCommunicationBehaviorCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesParalysis

Intervention Hierarchy (Ancestors)

Rehabilitation of Speech and Language DisordersRehabilitationAftercareContinuity of Patient CarePatient CareTherapeutics

Study Officials

  • Sudarshan Dayanidhi, PT, PhD

    Shirley Ryan AbilityLab

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Non-concurrent, multiple-baseline across participants
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 4, 2020

First Posted

February 7, 2020

Study Start

January 6, 2020

Primary Completion

May 26, 2020

Study Completion

May 26, 2020

Last Updated

September 21, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations